During the past decade, Taichung Veterans General Hospital; Division of Urology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Taichung Veterans General Hospital; Division of Urology" are "Renal Cell Carcinoma" (2 trials), "Bladder Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Metastatic Prostate Cancer" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Taichung Veterans General Hospital; Division of Urology" in a lesser frequency.

Most popular intervention types in "Taichung Veterans General Hospital; Division of Urology" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (3 trials), "Abiraterone" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Taichung Veterans General Hospital; Division of Urology" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Taichung Veterans General Hospital; Division of Urology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Taichung Veterans General Hospital; Division of Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Taichung Veterans General Hospital; Division of Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".